tirzepatide typical weight loss timeline Results Timeline: What to Expect Tirzepatide for Weight Loss |

Earlier this week, the company Hims, arguably the best-known source of compounded GLP-1s, announced that it would stop marketing these drugs as part of a truce formed with Novo Nordisk

Jastreboff AM, Aronne LJ, Ahmad NN, et al

While it does help your body release its own insulin more effectively in response to high blood sugar levels after a meal, it is not insulin itself and does not replace insulin therapy for those who require it, such as individuals with type 1 diabetes

It impairs insulin sensitivity, sometimes by as much as 30% after just four nights of poor sleep

You can read the abstract of this article at In the SURPASS-4 trial, the dual GIP and GLP-1 receptor agonist tirzepatide demonstrated superior reductions in HbA1c concentrations, bodyweight, and blood pressure compared to titrated daily insulin glargine in individuals with type 2 diabetes and cardiovascular risk

Make regular follow-up visits so your doctor can monitor your progress and make necessary adjustments to the dosage as needed